NGVT
Ingevity Corp
NYSE · Basic Materials · Chemicals - Specialty · US
$75.37
+1.62%Year over year
Reported trailing growth
- Revenue
- -12.4%
- EBITDA
- +473.8%
- EBIT
- -13.0%
- EPS
- +125.9%
- Free cash flow
- +3.1%
- Operating cash flow
- -2.0%
Forward estimates
Based on analyst estimates
- Revenue
- -2.7%
- EBITDA
- +113.9%
- EPS
- +272.8%
Three-year CAGR
- Revenue
- -11.2%
- EBITDA
- -56.0%
- EBIT
- -8.4%
- Net income
- +61.2%
- EPS
- +61.1%
- Free cash flow
- +17.0%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026